Genentech Set Back by Drug Study
wsj.com
Oct 6, 2008 35 related
        

Genentech Inc. and OSI Pharmaceuticals Inc. said a late-stage trial showed that adding the cancer medicine Avastin to the drug Tarceva didn't prolong the lives of patients with advanced lung cancer. The companies said, however,... [read full story]                    

Add Comment
There are also 35 related articles
View all news articles about*:
Cancers Genentech OSI Pharmaceuticals
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

Ifbyphone Secures $4.6 Million in New Round of Funding (Business Wire)

yahoo.com
3 mins ago 1 related
        

CHICAGO----In the middle of an economic slowdown and a drought in venture capital funding, Ifbyphone said today it has secured $4.6 million in a second round of institutional funding from five venture capital firms.

add comment

YOOX Brings Out The Big Jewels, If Abercrombie Won’t Mark Down We Won’t Buy, And More…

shefinds.com
3 mins ago
        

1. Online retailer YOOX debuts a jewelry section today comprised of modern and vintage costume baubles. Hit up YOOX now and get your holiday shopping out of the way. [FWD]2. Abercrombie & Fitch has reported significant losses...

add comment

Analysts' Upgrades, Downgrades: Citi (at TheStreet.com)

yahoo.com
4 mins ago
        

downgraded at Oppenheimer from Perform to Underperform. The company's two main end-markets are likely to remain under pressure into 2009. 2009 estimate also cut by 23%. BJ Services upgraded at Wachovia to Outperform. Survey...

add comment
yahoo.com: Miriam Metzinger yahoo.com

Fast Money Recap - Suffering in the Citi (11/17/08) (at Seeking Alpha)

yahoo.com
4 mins ago
        

by: SA Editor Miriam Metzinger November 18, 2008 | about stocks: SA Editor About this author: Recap of CNBC's Fast Money Program, Monday November 17. Painful Days and Mondays: XLF Amid news of a spreading global recession...

add comment